Larson Financial Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACRS
BCM
Larson Financial Group's ACRS Position: Q3 2026 in Review
Larson Financial Group opened a new position in Aclaris Therapeutics (ACRS) in Q3 2026: 433 shares worth $2.28K. The stake represents ﹤0.01% of the portfolio and ranks #3184 among its holdings.
167 funds tracked by Wall St. Rank hold ACRS as of Q3 2026.
- Larson Financial Group held 433 shares of Aclaris Therapeutics worth $2.28K as of Q3 2026.
- Aclaris Therapeutics was a new Larson Financial Group position in Q3 2026.
- Aclaris Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3184 holding.
- 167 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.